Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Cantab in-licenses Novasomes adjuvant for use in TA-CIN vaccine; clinical testing in sight

April 26, 1999

Promising results reported at AACR meeting from M-Vax trial in advanced melanoma

April 21, 1999

Recombinant immunotoxin for hematological malignancies from NCI evaluated in phase I

April 20, 1999

Immunological response to GMK melanoma vaccine examined as part of phase III trial

April 19, 1999

NIH investigates next-generation cancer immunotherapeutic

April 14, 1999

Preliminary analysis of Biomira's synthetic cancer vaccine

April 13, 1999

Onyvax awarded grant for cancer vaccines

April 13, 1999

Preclinical and clinical results with Virulizin in pancreatic cancer presented at AACR meeting

April 12, 1999

LeukoSite and Ilex hold pre-BLA meeting with FDA

April 12, 1999

GVAX prostate cancer vaccine enters additional phase I/II trial

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...